Post by Noemi Veraldi

Moving from Policy-Based to Architectural Trust in Pharma I’m at the Suglio Business Center today with Sebastiano Fuccio, the architect behind AlpGuard who is  based at the Fondazione AGIRE | Tecnopolo Ticino hub. In the Life Sciences, we are constantly navigating the tension between rapid AI innovation and the rigid regulatory requirements (FADP, EU AI Act) of our industry. For years, we’ve relied on policy-based compliance, but as data sensitivity grows, that’s no longer enough. Sebastiano is tackling this head-on by enforcing data sovereignty and auditability at the infrastructure layer. Why does this matter for our industry? ▶️ Deterministic Governance: biotech research handles proprietary, high-stakes data. We need #governance that is as precise and verifiable as the clinical trials themselves. ▶️ The 'Compliance by Design' Shift: having worked at Microsoft, Sebastiano is bringing enterprise-grade rigor to a boutique, sovereign Swiss framework. ▶️ Momentum: it’s been inspiring to watch the project’s trajectory, from semi-finalists at >>venture>> Startup Competition to active Innosuisse mentorship, with a current focus on Boldbrain Startup Challenge candidature and active market validation. We seem to be moving away from ‘ungoverned’ AI toward a future where research processes are verified independently and securely. For my network of AI specialists, researchers, and regulatory experts: how are you bridging the gap between rapid AI adoption and our industry's strict regulatory requirements? #SwissAI #LifeSciences #DataSovereignty #AlpGuard #TicinoInnovation #PharmaTech #DigitalTrust #SuglioBusinessCenter #Boldbrain #Innosuisse